简介内容:SEQ-9 is an orally active inhibitor targeting the Mycobacterium tuberculosis (Mtb) 23S bacterial ribosome, demonstrating an inhibitory concentration (IC50) around 170 nM against unmethylated Mtb ribosomes and showing potent effects on A2296 methylated ribosomes. This compound is utilized in researching bacterial infections and drug resistance [1].